Bayer Co.Lab Shanghai Launches as Part of Global Life Science Incubator Expansion
Friday, September 27, 2024
Bayer has announced the opening of its new life science incubator, Bayer Co.Lab Shanghai, located in the Shanghai Innovation Park within China’s largest biopharma hub, Zhangjiang.
As part of Bayer's global life science incubator network, which includes locations in Cambridge (USA), Kobe (Japan), and Berlin (Germany), the Shanghai facility marks a significant step in Bayer’s external innovation strategy.
Bayer Co.Lab Shanghai is designed to foster open collaboration within the biotech ecosystem by offering state-of-the-art labs, collaborative workspaces, and tailored support for start-ups. The incubator will serve as a vital platform to advance local innovation across the biopharmaceutical value chain.
Bayer Co.Lab Shanghai will connect start-ups to international innovation networks and partners, providing a supportive environment for growth and success. This launch highlights Bayer's ongoing investment in innovation within China and emphasizes its commitment to expanding in this critical market.
Through Bayer Co.Lab, the company aims to strengthen local partnerships and accelerate co-creation to drive healthcare innovation both in China and on a global scale.
Source: bayer.com
